HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hironaga Satake Selected Research
Hironaga Satake Research Topics
Disease
29
Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 01/2017
21
Neoplasms (Cancer)
07/2022 - 09/2017
13
Stomach Neoplasms (Stomach Cancer)
04/2022 - 01/2017
5
Adenocarcinoma
01/2022 - 09/2017
4
Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 09/2017
4
Neutropenia
12/2021 - 07/2020
3
Peripheral Nervous System Diseases (PNS Diseases)
04/2021 - 10/2019
3
Colonic Neoplasms (Colon Cancer)
01/2021 - 01/2018
3
Neoplasm Metastasis (Metastasis)
01/2021 - 01/2017
2
Rectal Neoplasms (Rectal Cancer)
02/2022 - 01/2017
2
Disease Progression
01/2020 - 12/2018
2
Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2019 - 01/2018
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2015 - 09/2012
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
12/2021
1
Febrile Neutropenia
12/2021
1
Venous Thromboembolism
09/2021
1
Hypertension (High Blood Pressure)
01/2021
1
Cachexia
01/2021
1
Chronic Disease (Chronic Diseases)
01/2021
1
Anorexia
01/2021
1
Proteinuria
01/2021
1
Exanthema (Rash)
01/2021
1
Fatigue
01/2021
1
Prostatic Neoplasms (Prostate Cancer)
10/2020
1
Diarrhea
07/2020
1
Melanoma (Melanoma, Malignant)
05/2020
1
Gastritis
11/2019
1
Fever (Fevers)
11/2019
1
Stomatitis
11/2019
1
Interstitial Lung Diseases (Interstitial Lung Disease)
11/2019
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
11/2019
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2019
1
Breast Neoplasms (Breast Cancer)
03/2019
1
Infections
02/2019
Drug/Important Bio-Agent (IBA)
21
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2022 - 01/2017
13
Bevacizumab (Avastin)
FDA Link
12/2021 - 01/2017
11
Irinotecan (Camptosar)
FDA Link
Generic
07/2022 - 01/2017
9
Fluorouracil (Carac)
FDA Link
Generic
01/2022 - 09/2012
6
trifluridine tipiracil drug combination
IBA
07/2022 - 01/2018
6
Capecitabine (Xeloda)
FDA Link
12/2021 - 01/2017
5
regorafenib
IBA
12/2021 - 01/2018
5
Gemcitabine
FDA Link
01/2021 - 09/2017
4
Nivolumab
IBA
07/2022 - 01/2018
4
Cetuximab (Erbitux)
FDA Link
06/2022 - 01/2018
4
Pharmaceutical Preparations
IBA
12/2021 - 01/2017
4
Cisplatin (Platino)
FDA Link
Generic
01/2020 - 07/2016
3
Trastuzumab (Herceptin)
FDA Link
07/2022 - 12/2018
3
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 11/2020
3
Leucovorin (Folinic Acid)
FDA Link
01/2022 - 01/2017
3
Panitumumab (Vectibix)
FDA Link
07/2021 - 06/2018
3
Ramucirumab
IBA
01/2021 - 11/2018
3
Platinum
IBA
10/2020 - 11/2018
2
Monoclonal Antibodies
IBA
01/2022 - 11/2020
2
Biomarkers (Surrogate Marker)
IBA
12/2021 - 11/2020
2
Immune Checkpoint Inhibitors
IBA
09/2021 - 05/2020
2
pembrolizumab
IBA
09/2021 - 10/2020
2
Thrombomodulin
IBA
04/2021 - 11/2020
2
aflibercept
IBA
01/2021 - 11/2020
2
XELOX
IBA
09/2017 - 01/2017
1
trastuzumab deruxtecan
IBA
04/2022
1
folfirinox
IBA
01/2022
1
Rivaroxaban
IBA
09/2021
1
Coagulants
IBA
09/2021
1
apixaban
IBA
09/2021
1
Therapeutic Uses
IBA
09/2021
1
edoxaban
IBA
09/2021
1
Anticoagulants
IBA
09/2021
1
Cholinergic Antagonists (Anticholinergics)
IBA
01/2021
1
Antihypertensive Agents (Antihypertensives)
IBA
01/2021
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2021
1
S 1 (combination)
IBA
01/2021
1
Dexamethasone (Maxidex)
FDA Link
Generic
01/2021
1
130-nm albumin-bound paclitaxel
IBA
01/2021
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2020
1
Antibodies
IBA
11/2020
1
Circulating Tumor DNA
IBA
11/2020
1
ART123
IBA
11/2020
1
Ligands
IBA
10/2020
1
Imatinib Mesylate (Gleevec)
FDA Link
11/2019
1
Sunitinib (Sutent)
FDA Link
11/2019
1
Paclitaxel (Taxol)
FDA Link
Generic
10/2019
1
pyrimidine
IBA
10/2019
1
Anaplastic Lymphoma Kinase
IBA
04/2019
1
Crizotinib
IBA
04/2019
1
2-(N-cyclohexylamino)ethanesulfonic acid (CHES)
IBA
03/2019
1
DNA (Deoxyribonucleic Acid)
IBA
02/2019
Therapy/Procedure
31
Drug Therapy (Chemotherapy)
06/2022 - 01/2017
21
Therapeutics
01/2022 - 09/2012
5
Adjuvant Chemotherapy
01/2021 - 01/2017
4
Chemoradiotherapy
02/2022 - 09/2012
4
Combination Drug Therapy (Combination Chemotherapy)
01/2022 - 01/2017
3
Neoadjuvant Therapy
01/2022 - 01/2017
3
Hepatectomy
01/2021 - 01/2018
3
Radiotherapy
01/2021 - 08/2015
2
Tracheostomy
08/2015 - 09/2011
1
Metastasectomy
02/2022
1
Palliative Care (Palliative Therapy)
01/2021
1
Activities of Daily Living (ADL)
01/2021
1
Drug Tapering
12/2020
1
Salvage Therapy
01/2020